ProLung Test is honored as “Most Innovative Non-Invasive Lung Cancer Testing Solution 2020” by Global Health & Pharma
ProLung has been awarded the “Most Innovative Non-Invasive Lung Cancer Testing Solution 2020” by Global Health & Pharma (GHP). Jared Bauer, ProLung CEO, commented, “I am incredibly proud of our team’s accomplishments over the past 18 months, and our resolve to expand the development of our Artificial Intelligence-driven Electrical Impedance Analytics (EIA) technology has never been stronger. When we receive external recognition on our progress and vision, it’s especially heart-warming.” Of particular note, ProLung was also honored by GHP in 2019 when they announced ProLung was their Medtech Company of the Year 2019.
Read the latest award in Global Health & Pharma’s Biotechnology Awards 2020 issue:
https://www.ghp-news.com/issues/biotechnology-awards-2020/10/